Publications | Lund University Publications

1 – 7 of 7

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=author+exact+%22med-cry%22+or+(documentType+any+%22bookEditor+conferenceEditor%22+and+editor+exact+%22med-cry%22)&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

2024
Mark Hepcidin, in contrast to heparin binding protein, does not portend acute kidney injury in patients with community acquired septic shock
Olinder, Jon ^LU ; Jovanovic Stjernqvist, Matilda ; Lindén, Albin ; Salomonsson, Evelina Thaphikul ^LU ; Annborn, Martin ^LU ; Herwald, Heiko ^LU and Rydén, Cecilia ^LU (2024) In PLoS ONE 19(5 MAY).
- Contribution to journal › Article
Mark The role of extracellular vesicle fusion with target cells in triggering systemic inflammation
Papareddy, Praveen ^LU ; Tapken, Ines ; Kroh, Keshia ; Varma Bhongir, Ravi Kiran ^LU ; Rahman, Milladur ^LU ; Baumgarten, Maria ^LU ; Cim, Eda Irem ; Györffy, Lilla ; Smeds, Emanuel ^LU and Neumann, Ariane ^LU , et al. (2024) In Nature Communications 15.
- Contribution to journal › Article
2023
Mark Identifying biomarkers deciphering sepsis from trauma-induced sterile inflammation and trauma-induced sepsis
Papareddy, Praveen ^LU ; Selle, Michael ; Partouche, Nicolas ; Legros, Vincent ; Rieu, Benjamin ; Olinder, Jon ^LU ; Ryden, Cecilia ^LU ; Bartakova, Eva ; Holub, Michal and Jung, Klaus , et al. (2023) In Frontiers in Immunology 14. p.1-16
- Contribution to journal › Article
2022
Mark Hepcidin discriminates sepsis from other critical illness at admission to intensive care
Olinder, Jon ^LU ; Börjesson, Alex ; Norrman, Jakob ; West, Tobias ; Carlström, Joakim ; Gustafsson, Alexander ; Annborn, Martin ^LU ; Herwald, Heiko ^LU and Rydén, Cecilia ^LU (2022) In Scientific Reports 12. p.1-16
- Contribution to journal › Article
2021
Mark COVIDENZA - A prospective, multicenter, randomized PHASE II clinical trial of enzalutamide treatment to decrease the morbidity in patients with Corona virus disease 2019 (COVID-19) : a structured summary of a study protocol for a randomised controlled trial
Welén, Karin ; Överby, Anna K. ; Ahlm, Clas ; Freyhult, Eva ; Robinsson, David ; Henningsson, Anna Jonsson ; Stranne, Johan ; Bremell, Daniel ; Angelin, Martin and Lindquist, Elisabeth , et al. (2021) In Trials 22(1).
- Contribution to journal › Letter
2020
Mark Plasma Levels of Hepcidin and Reticulocyte Haemoglobin during Septic Shock
Olinder, Jon ^LU ; Ehinger, Daniel ^LU ; Liljenborg, Erik ; Herwald, Heiko ^LU and Rydén, Cecilia ^LU (2020) In Journal of Innate Immunity 12(6). p.448-460
- Contribution to journal › Article
2016
Mark Evidence of household transfer of ESBL-/pAmpC-producing Enterobacteriaceae between humans and dogs - a pilot study
Ljungquist, Oskar ^LU ; Ljungquist, Ditte ; Myrenås, Mattias ; Rydén, Cecilia ^LU ; Finn, Maria and Bengtsson, Björn (2016) In Infection Ecology and Epidemiology 6.
- Contribution to journal › Article

your query:: Remove author: Rydén, Cecilia (LU)